Monsanto's mRNA Tech Linked to Vaccine Litigation

Bayer's Monsanto unit sued Pfizer, BioNTech, Moderna in Delaware and NJ for unspecified damages, not blocking vaccine production.
Monsanto developed messenger RNA technology in the 1980s to stabilize crops.
Bayer alleges Pfizer, BioNTech, and Moderna used this tech in their COVID-19 vaccines.
Moderna will defend itself, while Pfizer and BioNTech earned $3.3B from Comirnaty and Moderna $3.2B from Spikevax in 2024.
Lawsuits join existing patent disputes, including the 2022 Moderna v. Pfizer case.
Bayer bought Monsanto in 2018 for $66B and dropped the brand post-acquisition.

Legal | Corporate | Biotech

United States

2 weeks ago